Assessment of global phase uncertainty in case-control studies
<p>Abstract</p> <p>Background</p> <p>In haplotype-based candidate gene studies a problem is that the genotype data are unphased, which results in haplotype ambiguity. The <inline-formula><graphic file="1471-2156-10-54-i1.gif"/></inline-formula&g...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-09-01
|
Series: | BMC Genetics |
Online Access: | http://www.biomedcentral.com/1471-2156/10/54 |
id |
doaj-00b24109b10f4651b559df4267669b2a |
---|---|
record_format |
Article |
spelling |
doaj-00b24109b10f4651b559df4267669b2a2020-11-25T02:58:05ZengBMCBMC Genetics1471-21562009-09-011015410.1186/1471-2156-10-54Assessment of global phase uncertainty in case-control studiesvan Houwelingen Hans CPutter HeinHouwing-Duistermaat Jeanine JUh Hae-Won<p>Abstract</p> <p>Background</p> <p>In haplotype-based candidate gene studies a problem is that the genotype data are unphased, which results in haplotype ambiguity. The <inline-formula><graphic file="1471-2156-10-54-i1.gif"/></inline-formula> measure <abbrgrp><abbr bid="B1">1</abbr></abbrgrp> quantifies haplotype predictability from genotype data. It is computed for each individual haplotype, and for a measure of global relative efficiency a minimum <inline-formula><graphic file="1471-2156-10-54-i1.gif"/></inline-formula> value is suggested. Alternatively, we developed methods directly based on the information content of haplotype frequency estimates to obtain global relative efficiency measures: <inline-formula><graphic file="1471-2156-10-54-i2.gif"/></inline-formula> and <inline-formula><graphic file="1471-2156-10-54-i3.gif"/></inline-formula> based on A- and D-optimality, respectively. All three methods are designed for single populations; they can be applied in cases only, controls only or the whole data. Therefore they are not necessarily optimal for haplotype testing in case-control studies.</p> <p>Results</p> <p>A new global relative efficiency measure <inline-formula><graphic file="1471-2156-10-54-i4.gif"/></inline-formula> was derived to maximize power of a simple test statistic that compares haplotype frequencies in cases and controls. Application to real data showed that our proposed method <inline-formula><graphic file="1471-2156-10-54-i4.gif"/></inline-formula> gave a clear and summarizing measure for the case-control study conducted. Additionally this measure might be used for selection of individuals, who have the highest potential for improving power by resolving phase ambiguity.</p> <p>Conclusion</p> <p>Instead of using relative efficiency measure for cases only, controls only or their combined data, we link uncertainty measure to case-control studies directly. Hence, our global efficiency measure might be useful to assess whether data are informative or have enough power for estimation of a specific haplotype risk.</p> http://www.biomedcentral.com/1471-2156/10/54 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
van Houwelingen Hans C Putter Hein Houwing-Duistermaat Jeanine J Uh Hae-Won |
spellingShingle |
van Houwelingen Hans C Putter Hein Houwing-Duistermaat Jeanine J Uh Hae-Won Assessment of global phase uncertainty in case-control studies BMC Genetics |
author_facet |
van Houwelingen Hans C Putter Hein Houwing-Duistermaat Jeanine J Uh Hae-Won |
author_sort |
van Houwelingen Hans C |
title |
Assessment of global phase uncertainty in case-control studies |
title_short |
Assessment of global phase uncertainty in case-control studies |
title_full |
Assessment of global phase uncertainty in case-control studies |
title_fullStr |
Assessment of global phase uncertainty in case-control studies |
title_full_unstemmed |
Assessment of global phase uncertainty in case-control studies |
title_sort |
assessment of global phase uncertainty in case-control studies |
publisher |
BMC |
series |
BMC Genetics |
issn |
1471-2156 |
publishDate |
2009-09-01 |
description |
<p>Abstract</p> <p>Background</p> <p>In haplotype-based candidate gene studies a problem is that the genotype data are unphased, which results in haplotype ambiguity. The <inline-formula><graphic file="1471-2156-10-54-i1.gif"/></inline-formula> measure <abbrgrp><abbr bid="B1">1</abbr></abbrgrp> quantifies haplotype predictability from genotype data. It is computed for each individual haplotype, and for a measure of global relative efficiency a minimum <inline-formula><graphic file="1471-2156-10-54-i1.gif"/></inline-formula> value is suggested. Alternatively, we developed methods directly based on the information content of haplotype frequency estimates to obtain global relative efficiency measures: <inline-formula><graphic file="1471-2156-10-54-i2.gif"/></inline-formula> and <inline-formula><graphic file="1471-2156-10-54-i3.gif"/></inline-formula> based on A- and D-optimality, respectively. All three methods are designed for single populations; they can be applied in cases only, controls only or the whole data. Therefore they are not necessarily optimal for haplotype testing in case-control studies.</p> <p>Results</p> <p>A new global relative efficiency measure <inline-formula><graphic file="1471-2156-10-54-i4.gif"/></inline-formula> was derived to maximize power of a simple test statistic that compares haplotype frequencies in cases and controls. Application to real data showed that our proposed method <inline-formula><graphic file="1471-2156-10-54-i4.gif"/></inline-formula> gave a clear and summarizing measure for the case-control study conducted. Additionally this measure might be used for selection of individuals, who have the highest potential for improving power by resolving phase ambiguity.</p> <p>Conclusion</p> <p>Instead of using relative efficiency measure for cases only, controls only or their combined data, we link uncertainty measure to case-control studies directly. Hence, our global efficiency measure might be useful to assess whether data are informative or have enough power for estimation of a specific haplotype risk.</p> |
url |
http://www.biomedcentral.com/1471-2156/10/54 |
work_keys_str_mv |
AT vanhouwelingenhansc assessmentofglobalphaseuncertaintyincasecontrolstudies AT putterhein assessmentofglobalphaseuncertaintyincasecontrolstudies AT houwingduistermaatjeaninej assessmentofglobalphaseuncertaintyincasecontrolstudies AT uhhaewon assessmentofglobalphaseuncertaintyincasecontrolstudies |
_version_ |
1724708663449354240 |